David Bruce - Concepedia

Author

David Bruce

Also Known As

D Bruce, D W Bruce, D. Bruce, D. W. BRUCE, D. W. Bruce, D.W. Bruce, David Bruce, David W. Bruce, J. Furnace: S. Andole, K. Harkness

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Edinburgh University College London University of Nottingham National Hospital for Neurology and Neurosurgery University of Leicester

About

David Bruce is an author at University of Edinburgh specializing in medicine, pharmacology, and stroke.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	764
2	Public Health	1	1	137
3	Environmental Health	1	1	137
4	Hospital Medicine	1	1	555
5	Neurology	1	1	21

David Bruce

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial Martin Dennis, Gillian Mead, John Forbes, The Lancet	2018	276
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study Duncan Wilson, Gareth Ambler, Clare Shakeshaft, The Lancet Neurology	2018	248
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock, The Lancet	2019	188
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados, The Lancet Neurology	2018	177
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton, The Lancet	2017	176
The acute mammalian toxicity of rare earth nitrates and oxides David Bruce, Bernard E. Hietbrink, Kenneth P. DuBois Toxicology and Applied Pharmacology Environmental ChemistryReactive Nitrogen SpecieMedicineEnvironmental HealthToxicology	1963	137
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra, The Lancet Neurology	2019	88
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia Houwei Du, Duncan Wilson, Gareth Ambler, Stroke	2020	58

Page 1